Activated c-Abl is degraded by the ubiquitin-dependent proteasome pathway

A Echarri1, A M Pendergast

  • 1Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC 27710, USA.

Current Biology : CB
|November 24, 2001
PubMed

Insights

Activated c-Abl (Abelson murine leukemia virus oncogene homolog 1) is degraded via the ubiquitin-proteasome system. This pathway ensures downregulation of hyperactivated c-Abl, preventing oncogenic transformation and cytoskeletal pathway disruption.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Oncology

Background:

  • c-Abl is a nonreceptor tyrosine kinase crucial for cytoskeletal regulation.
  • Dysregulation and constitutive activation of c-Abl can lead to oncogenic transformation.
  • Mechanisms for downregulating activated c-Abl remain largely unknown.

Purpose of the Study:

  • To investigate the mechanisms responsible for the downregulation of activated c-Abl.
  • To determine if the ubiquitin-dependent degradation pathway plays a role in c-Abl regulation.

Main Methods:

  • Assessing c-Abl protein stability under various conditions.
  • Utilizing proteasome inhibition (26S proteasome) in vitro and in cell cultures.
  • Examining c-Abl ubiquitination in vivo.
  • Measuring tyrosine-phosphorylated endogenous c-Abl levels in fibroblasts.

Main Results:

  • Activated c-Abl forms exhibit greater instability compared to wild-type or kinase-inactive forms.
  • Inhibition of the 26S proteasome increases c-Abl levels.
  • Activated c-Abl proteins undergo ubiquitination in vivo.
  • Proteasome inhibition elevates tyrosine-phosphorylated endogenous c-Abl in fibroblasts.

Conclusions:

  • Activated c-Abl is downregulated through the ubiquitin-dependent degradation pathway.
  • This pathway provides a novel mechanism for irreversible downregulation of activated c-Abl.
  • Effective downregulation is critical for preventing adverse effects of c-Abl hyperactivation on cellular pathways.

Related Concept Videos

The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
The Proteasome Structure01:17

The Proteasome Structure

The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...